Výsledky vyhledávání

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Canadian Experience with Fingolimod: Adherence to Treatment and Monitoring

Autor: Marcelo Kremenchutzky, Y Lapierre, Robyn Schecter, Michael Yeung, Paul O'Connor, Mark S. Freedman, Virginia Devonshire

Publikováno v: Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 43:278-283

Background: The Canadian GILENYA® Go ProgramTM provides education and support to people with relapsing-remitting multiple sclerosis during fingolimod treatment. Methods: Data were collected and analyzed from the time of the first individual enrolled

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2d0c838e726701f6508b0eef391f148
https://doi.org/10.1017/cjn.2015.325

Zobrazit plný text záznamu

Multiple sclerosis (PP-038)

Autor: G. Fragoso, Christina Elliott, A. H. Nuyts, Y. Miyazaki, Y. Xu, T. Okazawa, H. Ochi, Y. Matsui, E. Montero, A. Mirshafiey, M. Izad, G. Lee, K. Fukuda, B. Balint, H. Kurata, A. Daniel Beyeen, E. S. Patrício, A. C. La Flamme, K. Shimano, T. Corona, H. Dougier-Reynaud, S. Miyake, H. Perron, T. Derfuss, E. Jouvin-Marche, T. Uede, D. O'Sulllivan, M. Hong, Reinhard Hohlfeld, S. Mader, M. Korporal, Z. Tan, R. Melarkode, S. Zhang, R. C. Dutra, Y. Lapierre, Z. Hruskova, T. Sugita, J. B. Pesquero, Z. N. Berneman, E. Kamali-Sarvestani, M. Khademi, P. Sämann, M. Trneny, M. Kadowaki, D. L. De la Cruz-Aguilera, B. Wildemann, H. Shinya, G. Nagels, Keyvan Ghasami, I. Kovarova, S. Vishwakarma, H. Mareckova, A. F. Bento, F. Gong, J. Gibbons, L. Duan, E. Zastepa, L. Aguirre-Cruz, D. Ganea, A. Tomita, A. Bar-Or, J. Antel, V. F. I. Van Tendeloo, J. Yen, D. Haegert, J. Hong, N. Yasuharu, L. Lee, C. Yao, J. Morimoto, Y. Yang, T. Okamoto, D. Sakata, J. Flores-Rivera, Ariel Arthur, Payani, Y. Esaki, J. K. M. Ng, M. Jagodic, Edgar Meinl, M. Krantz, Hema Mohan, Hartmut Wekerle, S. Jeon, J. Kira, I. Takaaki, M. Yanagida, M. Kharkrang, C. P. Figueiredo, W. Ma, T. S. Balmukhanov, M. Harirchian, N. Chihara, T. Yamamura, S. Satoru, Y. Miyamoto, K. Lenders, D. Hong, E. Krasulova, F. Zheng, W. Sato, M. Fang, L. Skacikova, N. Isobe, Z. Gheflati, B. Connor, D. Kurotaki, M. Ogawa, T. Olsson, E. Havrdova, H. Amiri Fard, Susan C. Barnett, S. Narumiya, J. Malotka, L. Chapul, L. Fitz-Gerald, J. Lee, B. Fritz, K. Motomura, T. Matsuoka, G. Tu, D. F. P. Leite, M. Koyama, H. Choi, K. Zenichiro, Ghasem Mosayebi, A. Fukunari, P. N. Marche, N. Seki, K. Ito, M. Vessal, E. Segi-Nishida, C. Bernard, Y. Kim, U. Makoto, P. Li, Y. Li, B. Agrawal, B. Willekens, A. Nikseresht, S. Zoghi, M. Minohara, Klaus Dornmair, X. Zeng, J. B. Calixto, A. Ortlieb Guerreiro-Cacais, S. Kim, F. Najafi, T. Matsushita, N. Cools, C. Lomparski, Yahya Jand, M. Kanayama, L. Steinman, S. Yoshimura, P. Nair, C. L. Villiers, K. Sugahara, Christopher Linington, R. H. Seong, K. Logronio, F. Satoshi, Hans Lassmann, T. Ikeda, H. Uga, M. Shin, M. Reindl, M. Ikeda, M. Rasband, D. Arnold, E. W. Loo, S. Tanaka, A. Duperray, S. He, D. Zhang, A. A. Smagin, N. A. Aitkhozhina, H. Kataoka, M. B. D'hooghe, J. Haas, R. Axtell, Z. Amirghofran, I. A. Goldina, Y. Funahashi, K. Chiba, M. r. Khazaei, T. Aranami, Ali Ghazavi, M. N. Manjavachi, F. Weber, S. M. Jeong, S. Patel, J. Lin, B. Stein, H. Bae, Y. Maeda, M. A. Mendesh, A. Schwarz, A. Jamshidian, Markus Krumbholz, K. Van Camp, T. Berger

Publikováno v: International Immunology. 22:i148-i155

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::15b46a77fd3f1f769d2a636c375c01b3
https://doi.org/10.1093/intimm/dxq125

Zobrazit plný text záznamu

P.068 Real world experience with Fingolimod in Canada

Autor: Y Lapierre, P Haddad, Jiwon Oh, Virginia Devonshire, Robyn Schecter, Virender Bhan, JM Burton, Sarah A. Morrow, Francois Emond

Publikováno v: Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 44:S30-S30

Background: The Gilenya® Go ProgramTM offers education and support services, including coordination of first dose observation (FDO) and follow-up contact to reinforce monitoring recommendations and compliance in fingolimod-treated relapsing-remittin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::35176f1f8c2c7953dd593eb55284a251
https://doi.org/10.1017/cjn.2017.152

Zobrazit plný text záznamu

Les tests en gel et leur évolution

Autor: Y. Lapierre

Publikováno v: Transfusion Clinique et Biologique. 1:115-119

The gel test is born in 1984. Its evolution can be described in three steps: development of a marketable product by the Diamed company improvement of this product, and development of new products based on the same process by competitors. Its main app

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e1614527f85062d20654fbe00840a17c
https://doi.org/10.1016/s1246-7820(94)80006-5

Zobrazit plný text záznamu

The Global Adherence Project (GAP): a multicenter observational study on adherence to disease-modifying therapies in patients with relapsing-remitting multiple sclerosis

Autor: V, Devonshire, Y, Lapierre, R, Macdonell, C, Ramo-Tello, F, Patti, P, Fontoura, L, Suchet, R, Hyde, I, Balla, E M, Frohman, B C, Kieseier, A, Soto

Publikováno v: European journal of neurology. 18(1)

most disease-modifying therapies (DMTs) for multiple sclerosis (MS) are self-injectable medications that must be taken on an ongoing basis to reduce disease activity. Thus, adherence to therapy becomes an important challenge that must be addressed to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::cbb2a9cf41557504471fa17e9da1c58d
https://pubmed.ncbi.nlm.nih.gov/20550560

Zobrazit plný text záznamu